These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29894324)

  • 1. Capecitabine-Associated Myocardial Infarction.
    Tariq Z; Mudge R; Phillips S
    Am J Ther; 2018; 25(6):e737-e739. PubMed ID: 29894324
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple inflammatory lesions in an oncology patient.
    Pigem R; Maroñas-Jiménez L; Pau-Charles I; Mascaró JM
    Int J Dermatol; 2016 Dec; 55(12):1301-1303. PubMed ID: 26710313
    [No Abstract]   [Full Text] [Related]  

  • 3. Unilateral Capecitabine-related Hand-foot Syndrome.
    Matsuda S; Koketsu H; Hayakawa M; Nagata N
    Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
    [No Abstract]   [Full Text] [Related]  

  • 4. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
    Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
    Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary mania following cancer chemotherapy with capecitabine.
    Garg H; Prakash S; Deb KS; Chadda RK
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29599381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine.
    Lampropoulos S; Roditis P; Koulouris E; Zafiris A; Tzimou M; Kyratlidis K; Pavlidis K; Godwin SA; Kosmas C
    Anticancer Drugs; 2017 Aug; 28(7):801-807. PubMed ID: 28489615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.
    Kwakman JJ; Simkens LH; Mol L; Kok WE; Koopman M; Punt CJ
    Eur J Cancer; 2017 May; 76():93-99. PubMed ID: 28286287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
    Polk A; Shahmarvand N; Vistisen K; Vaage-Nilsen M; Larsen FO; Schou M; Nielsen DL
    BMJ Open; 2016 Oct; 6(10):e012798. PubMed ID: 27798021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Cases of Capecitabine-Induced Ileitis in Patients Treated with Radiochemotherapy to the Pelvis and Review of the Literature.
    Nicosia L; Russo I; De Sanctis V; Minniti G; Valeriani M; Osti MF
    J Gastrointest Cancer; 2018 Dec; 49(4):538-542. PubMed ID: 28547118
    [No Abstract]   [Full Text] [Related]  

  • 10. Capecitabine Toxicity and Dihydropyrimidine Dehydrogenase Deficiency.
    Tariq Z; Mudge R; Phillips S
    Am J Ther; 2018; 25(6):e742-e743. PubMed ID: 29889674
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of palmoplantar dysesthesia syndrome caused by capecitabine].
    Elmas ÖF; Metin MS; Kızılyel O; Aktaş A; Birdal C
    Agri; 2016 Jan; 28(1):54-6. PubMed ID: 27225615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma.
    Lu B; Bao LB; Sun Z; Hua ZL; Wang X; Qu CP
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3605-12. PubMed ID: 26502850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant capecitabine for HER2-negative breast cancer.
    Burki TK
    Lancet Oncol; 2017 Jul; 18(7):e375. PubMed ID: 28602775
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
    Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S
    J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.
    Nikolic-Tomasevic Z; Jelic S; Cassidy J; Filipovic-Ljeskovic I; Tomasevic Z
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):594-602. PubMed ID: 16044340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
    Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia.
    Ozaslan E; Eroglu E; Gok K; Senel S; Baldane S; Akyol L; Ozkan M
    Rom J Intern Med; 2015; 53(3):282-5. PubMed ID: 26710505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine-Related Thrombotic Microangiopathy.
    Mateo FJP; Guasch AD; Pineda JAG; Manrique ACV; Cullell BM; López-Bravo DP; Díaz JG; Cascón AP; Freiria XB
    J Gastrointest Cancer; 2024 Jun; 55(2):965-968. PubMed ID: 38175385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndrome secondary to fluorouracil infusion.
    Lu JI; Carhart RL; Graziano SL; Gajra A
    J Clin Oncol; 2006 Jun; 24(18):2959-60. PubMed ID: 16782933
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care.
    Meulendijks D; van Hasselt JGC; Huitema ADR; van Tinteren H; Deenen MJ; Beijnen JH; Cats A; Schellens JHM
    Eur J Cancer; 2016 Feb; 54():120-130. PubMed ID: 26761784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.